I'll repost this in case anyone has anything they'd like to add to the list....
Come on now let's get real....there is ONE product on Amazon with 18 reviews, and Cannophen is likely to be a retail CBD product (meaning derived from hemp not marijuana). There are already TONS of such CBD quick buck products everywhere, I have even seen them in some gas station convenience stores.
The day this company puts out a product that is ACTUALLY a MARIJUANA PRODUCT or a cannabis derived CBD product, then maybe eventually there will be revenues.
BUT don't look for profits until:
1. PAOG asset acquisition costs are recouped (we don't even know what the assets are)
2. building a laboratory in Ohio construction costs are recouped
3. the cost of hiring, "training", and paying their chemist in Florida is recouped
4. cost of buying & remodeling Pittsburgh "facility" is recouped
5. cost of hiring a "professional PR firm" are recouped
6. cost of hiring a professional firm "to become a fully audited & reporting company" are recouped
7. cost of testing ginger menthol pain cream with ABICH are recouped (TSW on sale nowhere currently)
8. cost of peptide scar serum production are recouped (currently only for sale on Amazon)
9. costs of establishing a new business entity in Canada are recouped
10. I don't even what to say about the costs they are implying with whatever Cannophen actually is are recouped
11. the costs of their trips to California, Arizona, Ohio, Pennsylvania etc to "seek licensing" are recouped
Am I forgetting anything the company has told us they are doing ???
